Intercept Pharmaceuticals reported $93.08M in Equity Capital and Reserves for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US USD 400.41M 25.27M
Acorda Therapeutics ACOR:US USD 93.62M 17.86M
Alnylam Pharmaceuticals ALNY:US USD -158223000 90.58M
Amarin AMRN:US USD 587.83M 7.78M
Amgen AMGN:US USD 3.66B 8M
Arrowhead Research ARWR:US USD 377.04M 21.48M
AstraZeneca AZN:LN USD 37.04B 1.9B
Biogen BIIB:US USD 13.4B 622.4M
Bluebird Bio BLUE:US USD 158.86M 21.26M
Enanta Pharmaceuticals ENTA:US USD 300.84M 20.5M
Esperion Therapeutics ESPR:US USD -323778000 29.68M
Galectin Therapeutics GALT:US USD -22335000 7.11M
Gilead Sciences GILD:US USD 21.21B 128M
GlaxoSmithKline GSK:LN GBP 10.6B 1.45B
Intercept Pharmaceuticals ICPT:US USD 93.08M 14.6M
Moderna Inc MRNA:US USD 19.12B 1.13B
Neurocrine Biosciences NBIX:US USD 1.71B 163.2M
Novartis NOVN:VX USD 59.34B 1.48B
Ptc Therapeutics PTCT:US USD -347086000 120.18M
Regeneron Pharmaceuticals REGN:US USD 22.66B 1.23B
Sangamo Biosciences SGMO:US USD 294.96M 14.2M
Sarepta Therapeutics SRPT:US USD 384.95M 45.89M
Vertex Pharmaceuticals VRTX:US USD 13.91B 883.1M
YTE INCY:US USD 4.37B 143.47M